Almanack Investment Partners, Llc. Becton Dickinson & CO Transaction History

Almanack Investment Partners, Llc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$218.29 - $256.91 $33,398 - $39,307	-153 Reduced 7.45%	1,901 $483,000
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $62,001 - $321,039	-1,215 Reduced 37.17%	2,054 $458,000
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $238,026 - $279,275	1,014 Added 44.97%	3,269 $806,000
Q1 2022 May 13, 2022	SELL	$243.64 - $270.48 $17,785 - $19,745	-73 Reduced 3.14%	2,255 $600,000
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $1,610 - $1,756	7 Added 0.3%	2,328 $586,000
Q2 2021 Aug 04, 2021	SELL	$232.65 - $254.58 $75,843 - $82,993	-326 Reduced 12.32%	2,321 $564,000
Q1 2021 May 11, 2021	BUY	$232.09 - $256.88 $289,880 - $320,843	1,249 Added 89.34%	2,647 $644,000
Q4 2020 Feb 03, 2021	BUY	$221.92 - $245.94 $65,466 - $72,552	295 Added 26.75%	1,398 $350,000
Q3 2020 Nov 12, 2020	BUY	$215.77 - $276.76 $55,668 - $71,404	258 Added 30.53%	1,103 $265,000
Q2 2020 Aug 10, 2020	BUY	$219.9 - $263.41 $185,815 - $222,581	845 New	845 $202,000
Q3 2019 Nov 08, 2019	SELL	$230.58 - $256.08 $99,149 - $110,114	-430 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$217.4 - $246.08 $93,482 - $105,814	430 New	430 $0
Q4 2018 Jan 25, 2019	SELL	$204.73 - $257.93 $88,033 - $110,909	-430 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $2,330 - $2,560	-10 Reduced 2.27%	430 $102,000
Q2 2018 Aug 15, 2018	BUY	$208.1 - $233.85 $91,564 - $102,894	440 New	440 $105,000
Q1 2018 May 15, 2018	SELL	$205.46 - $240.27 $104,990 - $122,777	-511 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$189.0 - $222.64 $96,579 - $113,769	511	511 $109,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

Stay updated on Almanack Investment Partners, Llc. with notifications on news.